Vertex Pharmaceuticals Email Format

Biotechnology Research
5,001-10,000 employees
Boston, MA, USA

Vertex Pharmaceuticals is a global biotechnology company that develops transformative medicines for serious diseases including cystic fibrosis, sickle cell disease, and genetic disorders.

Find contacts at Vertex Pharmaceuticals

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first_last@vrtx.com

Company Overview

Industry
Biotechnology Research
Founded
1989
Headquarters
Boston, MA, USA
Revenue
$10B-$25B
FUNDING Stage
Public
Key Executives
Reshma Kewalramani (Chief Executive Officer and President), Charles F. Wagner (Executive Vice President and Chief Operating & Financial Officer), Agam Upadhyay (Senior Vice President, Chief Digital and Information Officer)

Tech Stack

Snowflake

Analytics

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Vertex Pharmaceuticals?

Vertex Pharmaceuticals uses the first_last format on vrtx.com, so Jane Smith would be jane_smith@vrtx.com.

What approved medicines does Vertex Pharmaceuticals currently market for cystic fibrosis?

Vertex Pharmaceuticals markets several approved cystic fibrosis therapies, including TRIKAFTA (elexacaftor/tezacaftor/ivacaftor), which is indicated for patients aged 2 and older who carry at least one eligible genetic variant. The company has spent more than 20 years developing treatments that address the underlying cause of CF.

How does Vertex Pharmaceuticals' gene-editing therapy Casgevy work?

Casgevy, developed with CRISPR Therapeutics, is a one-time ex vivo CRISPR/Cas9 gene-edited cell therapy approved for eligible patients with sickle cell disease and transfusion-dependent beta-thalassemia. It was the first CRISPR-based therapy to receive FDA approval, in December 2023.

Where does Vertex Pharmaceuticals have research and office locations outside the United States?

Vertex Pharmaceuticals has international operations across Europe, including a UK headquarters in Paddington, London, as well as a research facility in Milton Park, Oxfordshire. The company also has a presence in Australia and markets across France, Germany, Italy, Spain, and the GCC region.

Who leads Vertex Pharmaceuticals as CEO, and can Clay help me find the right contact there?

Reshma Kewalramani serves as Chief Executive Officer and President of Vertex Pharmaceuticals. If you need to reach a specific contact at Vertex, Clay can help you verify email addresses and enrich your prospect list with up-to-date details.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles